Ninety-three percent of patients do not correctly apply eye drops they were prescribed after cataract surgery, which means introducing new drug routes, says Francis S. Mah. MD.
OptiMedica Corp. has received a patent for the Catalys Precision Laser System relating to the fundamental technology underlying laser cataract surgery.
Bausch + Lomb and CROMA have donated 50,000 units of bromfenac sodium sesquihydrate (Yellox) to projects in Africa sponsored by Light for the World.
Alcon has announced the launch of nepafenac ophthalmic suspension 0.3% (Ilevro), a new once-daily treatment option for pain and inflammation associated with cataract surgery.